Editorial & Commercial Disclosure

Mitochondria Report may link to ReCellence and other commercial products. Some links may create a commercial benefit for the site owner. Commercial relationships do not permit us to manufacture product facts, clinical findings or competitor claims.

Why disclosure matters

Affiliate relationships, sponsorships, samples, and preferred commercial relationships can distort product recommendations.

Affiliate and commercial links

Some links may create revenue or another commercial benefit. Those links do not count as independent evidence of effectiveness.

ReCellence relationship

MitochondriaReport may direct readers to ReCellence. That pathway should remain disclosed rather than disguised as neutral third-party endorsement.

Editorial independence

Commercial relationships do not permit a merchant to rewrite conclusions, suppress relevant negatives, or turn marketing claims into scientific conclusions.

Product samples

Receiving a sample should not guarantee coverage, positive treatment, or ranking placement.

Database integrity

Database fields should remain source-backed. Missing values should remain missing rather than being inferred.

Corrections

Manufacturers can submit factual corrections with current documentation. Corrections should be judged on evidence, not commercial status.

Reader responsibility

Disclosure improves transparency, but readers should still verify current labels, warnings, prices, and terms before purchase.

Update trigger 1

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 2

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 3

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 4

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 5

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 6

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 7

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 8

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 9

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 10

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 11

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 12

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 13

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 14

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 15

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 16

For Editorial & Commercial Disclosure, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.